# Congressional stock trades in FTRE (Fortrea Holdings Inc. Common Stock)

Congressional stock trades in Fortrea Holdings Inc. Common Stock (FTRE) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.

- Industry: Services-Medical Laboratories
- Last close: $19.93
- Price updated: Sep 21, 2026
- Total congressional trades: 1
- Politicians trading: 1
- Last traded: Jun 23, 2025
- Source: https://tryglasshouse.ai/companies/FTRE.md

## Trading History

- Page: 1 of 1
- Results: 1 of 1
- Pagination query parameter: `page`

## 1. J. French Hill

- Member: Republican, House
- Transaction: Sell, $1,001 - $15,000
- Dates: traded Jun 23, 2025, disclosed Jul 24, 2025
- Market context: $5.1 at trade, $19.93 current (+290.78%)
- Politician: https://tryglasshouse.ai/politicians/H001072.md
- Record: https://tryglasshouse.ai/trades/af214604-2b26-4be7-a787-8d58ff1813d3.md



## About Fortrea Holdings Inc. Common Stock

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Prices and percentage changes are market context, not portfolio returns. This information is not financial advice.